ACCC, ASCO, & NCCN News

The following information has been received by ANCO.


****ACCC NEWS****
The Association of Community Cancer Center's (ACCC) This Week At ACCC was published and is available online at http://www.accc-cancer.org/mediaroom/newsletters/2009/media_ACCCNEWSLETTER_2-2-2009.html. ANCO is an Institutional Member of ACCC. This edition features:

ACCC Submits Comments on AHRQ Draft Comparative Effectiveness Review

CMS Officials, Congressional Reps to Speak at ACCC's Annual National Meeting

Clinicians, Cooperative Groups Work through Leucovorin Shortage

Senate Passes SCHIP Reauthorization; President Expected to Sign Legislation

Q&A on ACCC's Listserv: Leucovorin Shortage

ACCC's CE Blackboard: A Full Range of Courses

ACCC Is Now on Facebook

State Medical Oncology Societies Host Membership Meetings


****ASCO NEWS****
The American Society of Clinical Oncology's (ASCO) e-News was published and is available online at http://view.exacttarget.com/?j=fe5b15787c660679741d&m=ff2d16787160&ls=fdf313717664027a711d7072&l=fe5c1575716d077d7c10&s=fdf2157972640d79751d7073&jb=ffcf14&ju=fe3516727561047b751275. ANCO is state/regional affiliate of ACCC. This edition features:

Visit ASCO's EHR Social Network Site

ASCO Releases its First Provisional Clinical Opinion (PCO)

Newest Issue of ASCO News & Forum Available Online

Read the JCO Original Report, "Reproduction Rates After Cancer Treatment: Experience From the Norwegian Radium Hospital"

Read the Recent JOP feature, "Tobacco Cessation and Quality Cancer Care"

Virtual Meeting, Podcast Access for the 2009 GU Cancers Symposium Available for Purchase

Electronic Resources Now Available from the 2009 GI Cancers Symposium

Cancer Policy Alert: ASCO Urges Lawmakers to Exclude Prompt Pay Discounts from ASP; Oncology Added to Draft CCHIT Roadmap; Chemotherapy Administration Safety Standards Are Available for Public Comment

Cancer.Net Feature: Secondhand Smoke and Cancer

Cancer.Net Feature: Having a Child After Cancer Treatment

Cancer.Net Podcasts


****NCCN NEWS****
NCCN Chemotherapy Order Templates™ based on the NCCN Clinical Practice Guidelines in Oncology™ and the NCCN Drugs & Biologics Compendium™

Newly released NCCN Chemotherapy Order Templates™:

• Colon Cancer

• Hepatobiliary Cancers

NCCN is developing a library of chemotherapy order templates to improve the safe use of drugs and biologics in cancer care. The information contained in the Templates is based on the NCCN Clinical Practice Guidelines in Oncology™ and the NCCN Drugs & Biologics Compendium™. The Templates include chemotherapy, hormone therapy, immunotherapy, supportive care agents, monitoring parameters, and safety instructions. Special instructions for self-administered chemotherapeutic agents are provided.

The following Templates are now available: Bladder Cancer, Breast Cancer, Cervical Cancer, Chronic Myelogenous Leukemia, Colon Cancer, Hepatobiliary Cancers, Kidney Cancer, Ovarian Cancer, Prostate Cancer, Small Cell Lung Cancer and Testicular Cancer.

Coming Soon: Acute Myeloid Leukemia, Bone Cancer, Central Nervous System Cancers, Chronic Lymphocytic Leukemia, Esophageal Cancer, Gastric Cancer, Head and Neck Cancers, Hodgkin Disease/Lymphoma, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neuroendocrine Tumors, Non-Hodgkin's Lymphoma, Non-Melanoma Skin Cancers, Non-Small Cell Lung Cancer, Occult Primary, Pancreatic Adenocarcinoma, Rectal Cancer, Soft Tissue Sarcoma, Thyroid Carcinoma, and Uterine Neoplasms.

Disclaimer: These templates are a peer-reviewed statement of the consensus of the authors derived from the NCCN Clinical Practice Guidelines in Oncology™ regarding their views of currently accepted approaches to treatment. These templates do not constitute orders. Any clinician seeking to treat a patient using the templates is expected to use independent medical judgment in the context of individual clinical circumstances of a specific patient’s care or treatment. NCCN disclaims all warranties, express or implied including, without limitation, the implied warranties of merchantability and fitness for a particular purpose. NCCN does not warrant the accuracy, currency or completeness of the templates or make any representation regarding the use or the results of the use of the templates in treatment. In no event shall NCCN or its members be liable for any damages including without limitation incidental, indirect, special, punitive or consequential damages arising out of or
in connection with the use of the templates including, without limitation, loss of life, loss of data, loss of income or profit, losses sustained as a result of any injury to any person, or loss or damage to property or claims of third parties. © 2008/2009 National Comprehensive Cancer Network

Access the latest updates at www.nccn.org.